High mobility group box-1 recognition: The beginning of a RAGEless era?

被引:17
|
作者
Branco-Madeira, Filipe [1 ]
Lambrecht, Bart N. [1 ]
机构
[1] Ghent Univ Hosp, Lab Immunoregulat & Mucosal Immun, Dept Resp Dis, B-9000 Ghent, Belgium
关键词
HMGB1; inflammation; TLR4; HMGB1;
D O I
10.1002/emmm.201000077
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
High mobility group box 1 (HMGB1) is a molecular alarm signal that triggers an immune response when released. It was assumed that the receptor for advanced glycation end-products (RAGE) would mediate the signal to the immune system. Recently pattern recognition receptors that are triggered by molecules of bacterial origin (the Tolllike receptor (TLR) family) were shown to also respond to HMGB1. Now two papers establish the TLR4-HMGB1 axis as proinflammatory, eventually leading to disparate conditions like seizures or skin cancer. These reports add a new twist to our understanding of the mode of action of the alarm signal HMGB1. © 2010 EMBO Molecular Medicine.
引用
收藏
页码:193 / 195
页数:3
相关论文
共 50 条
  • [41] Decreased expression of sirtuin 6 is associated with release of high mobility group box-1 after cerebral ischemia
    Lee, Ok-Hee
    Kim, Jayoung
    Kim, Jin-Moo
    Lee, Hyunji
    Kim, Eun Hee
    Bae, Soo-Kyung
    Choi, Youngsok
    Nam, Hyo Suk
    Heo, Ji Hoe
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 438 (02) : 388 - 394
  • [42] Levels of high-mobility group box-1 in gingival crevicular fluid in nonsmokers and smokers with chronic periodontitis
    Lin, Yi-Chun
    Wu, Ching-Yi
    Chang, Lien-Yu
    Chen, Ching-Chu
    Chen, Hsuan-Hung
    Lai, Yu-Lin
    Hung, Shan-Ling
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (12) : 933 - 939
  • [43] High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson’s disease
    Aslıhan Baran
    Mahmut Bulut
    Mehmet Cemal Kaya
    Özlem Demirpençe
    Bünyamin Sevim
    Eşref Akıl
    Sefer Varol
    Neurological Sciences, 2019, 40 : 167 - 173
  • [44] High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson's disease
    Baran, Aslihan
    Bulut, Mahmut
    Kaya, Mehmet Cemal
    Demirpence, Ozlem
    Sevim, Bunyamin
    Akil, Esref
    Varol, Sefer
    NEUROLOGICAL SCIENCES, 2019, 40 (01) : 167 - 173
  • [45] Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
    Chung, Hye Won
    Lee, Sang-Guk
    Kim, Heejung
    Hong, Duck Jin
    Chung, Jae Bock
    Stroncek, David
    Lim, Jong-Baeck
    JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7
  • [46] High-Mobility Group Box-1 Mediates Toll-Like Receptor 4-Dependent Angiogenesis
    Lin, Qing
    Yang, Xiao Ping
    Fang, Dan
    Ren, Xiangrong
    Zhou, Hongyan
    Fang, Jiazhu
    Liu, Xialin
    Zhou, Shiyou
    Wen, Feng
    Yao, Xiaohong
    Wang, Ji Ming
    Su, Shao Bo
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (05) : 1024 - U174
  • [47] Macrophages-derived high-mobility group box-1 protein induces endothelial progenitor cells pyroptosis
    Zeng, Menghao
    Liang, Guibin
    Yuan, Fangfang
    Yan, Shanshan
    Liu, Jie
    He, Zhihui
    ISCIENCE, 2024, 27 (10)
  • [48] Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock
    Sundén-Cullberg, J
    Norrby-Teglund, A
    Rouhiainen, A
    Rauvala, H
    Herman, G
    Tracey, KJ
    Lee, ML
    Andersson, J
    Tokics, L
    Treutiger, CJ
    CRITICAL CARE MEDICINE, 2005, 33 (03) : 564 - 573
  • [49] Expression of high-mobility group box-1 (HMGB1) in the basilar artery after experimental subarachnoid hemorrhage
    Zhao, Xu Dong
    Mao, Hai Yan
    Lv, Jing
    Lu, Xiao Jie
    JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 27 : 161 - 165
  • [50] Systemic High-Mobility Group Box-1: A Novel Predictive Biomarker for Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage*
    Chaudhry, Shafqat R.
    Gueresir, Agi
    Stoffel-Wagner, Birgit
    Fimmers, Rolf
    Kinfe, Thomas M.
    Dietrich, Dirk
    Lamprecht, Alf
    Vatter, Hartmut
    Gueresir, Erdem
    Muhammad, Sajjad
    CRITICAL CARE MEDICINE, 2018, 46 (11) : E1023 - E1028